Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-30
2010-06-15
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S557000, C514S570000, C514S575000, C514S617000
Reexamination Certificate
active
07737175
ABSTRACT:
The present invention provides methods and compositions for modulating HDAC4 activity and modulating the activity of proteins downstream of HDAC4 in the muscle transcriptional pathway in a cell by modulating HDAC4 activity. Further provided are methods and compositions for treating muscle atrophy and/or inflammation by inhibiting HDAC4 activity.
REFERENCES:
patent: 6541661 (2003-04-01), Delorme et al.
patent: 6673587 (2004-01-01), Evans et al.
patent: 6706686 (2004-03-01), Long et al.
patent: 6809118 (2004-10-01), Chung
patent: 7229963 (2007-06-01), Sartorelli et al.
patent: 7557141 (2009-07-01), Mishra et al.
patent: 2003/0082666 (2003-05-01), Kammer et al.
patent: 2003/0144340 (2003-07-01), Long et al.
patent: 2003/0148970 (2003-08-01), Besterman et al.
patent: 2003/0152557 (2003-08-01), Besterman et al.
patent: 2003/0206946 (2003-11-01), Chung
patent: 2004/0024067 (2004-02-01), Remiszewski et al.
patent: 2004/0077083 (2004-04-01), Watt
patent: 2004/0077084 (2004-04-01), Watt
patent: 2005/0014839 (2005-01-01), Kozikowski et al.
patent: 2006/0030626 (2006-02-01), Kammer et al.
patent: 2006/0178437 (2006-08-01), Kammer et al.
patent: 2007/0207950 (2007-09-01), Yao et al.
patent: 2009/0076021 (2009-03-01), Plato
patent: 2009/0118291 (2009-05-01), Belvedere et al.
patent: 2009/0181943 (2009-07-01), Tessier et al.
patent: WO 03/033678 (2003-04-01), None
patent: WO 03/076430 (2003-09-01), None
patent: WO/2006026260 (2006-03-01), None
patent: WO 2007/100795 (2007-09-01), None
Adams and Goldman. “Role for Calcium From the Sarcoplasmic Reticulum in Coupling Muscle Activity to Nicotinic Acetylcholine Receptor Gene Expression in Rat”J Neurobiol35:245-257 (1998).
Backs et al. “CaM Kinase II Selectively Signals to Histone Deacetylase 4 During Cardiomyocyte Hypertrophy”The Journal of Clinical Investigation116(7):1853-1864 (2006).
Banks et al. “The Postsynaptic Submembrane Machinery at the Neuromuscular Junction: Requirement for Rapsyn and the Utrophin/Dystrophin-Associated Complex”Journal of Neurocytology32:709-726 (2003).
Bassel-Duby and Olson. “Signaling Pathways in Skeletal Muscle Remodeling”Annu Rev Biochem75:19-37 (2006).
Bessereau et al. “In Vivo and In Vitro Analysis of Electrical Activity-Dependent Expression of Muscle Acetylcholine Receptor Genes Using Adenovirus”Proc Natl Acad Sci USA91:1304-1308 (1994).
Blake et al. “Utrophin: A Structural and Functional Comparison to Dystrophin”Brain Pathol6(1):37-47 (1996) (Abstract Only).
Bodine et al. “Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy”Science294:1704-1708 (2001).
Bolger and Yao. “Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death”The Journal of Neuroscience25(41):9544-9553 (2005).
Bolger et al. “The Neurodegenerative Disease Protein Ataxin-1 Antagonizes the Neuronal Survival Function of Myocyte Enhancer Factor-2”Journal of Biological Chemistry282(40):29186-29192 (2007).
Cohen et al. “The Histone Deacetylase HDAC4 Connects Neural Activity to Muscle Transcriptional Reprogramming”Journal of Biological Chemistry282(46):33752-33759 (2007).
Cohen et al. “The Histone Deacetylase HDAC4 Links Neural Activity to Transcriptional Reprogramming” Poster presentation at Gordon Research Conference entitled “Myogenesis,” Lucca, Italy (May 13-18, 2007).
Cox et al. “Identification of the Mouse Neuromuscular Degeneration Gene and Mapping of a Second Site Suppressor Allele”Neuron21:1327-1337 (1998).
Grady et al. “Maturation and Maintenance of the Neuromuscular Synapse: Genetic Evidence for Roles of the Dystrophin-Glycoprotein Complex”Neuron25:279-293 (2000).
Gundersen et al. “Overexpression of Myogenin in Muscles of Transgenic Mice: Interaction with Id-1, Negative Crossregulation of Myogenic Factors, and Induction of Extrasynaptic Acetylcholine Receptor Expression”Molecular and Cellular Biology15(12):7127-7134 (1995).
Huang and Schmidt. “Calcium Influx Blocks the Skeletal Muscle Acetylcholine Receptor α-Subunit Gene in Vivo”FEBS Letters338:277-280 (1994).
Klarsfeld and Changeux. “Activity Regulates the Levels of Acetylcholine Receptor α-Subunit mRNA in Cultured Chicken Myotubes”Proc Natl Acad Sci USA82:4558-4562 (1985).
Lu et al. “Signal-Dependent Activation of the MEF2 Transcription Factor by Dissociation From Histone Deacetylases”Proc Natl Acad Sci USA97(8):4070-4075 (2000).
MacPherson et al. “Activity-Dependent Gene Regulation in Conditionally-Immortalized Muscle Precursor Cell Lines”Journal of Cellular Biochemistry91:821-839 (2004).
MacPherson et al. “Myogenin-Dependent nAChR Clustering in Aneural Myotubes”Mol Cell Neurosci31:649-660 (2006).
MacPherson et al. “Protein Kinase C and Calcium/Calmodulin-Activated Protein Kinase II (CaMK II) Suppress Nicotinic Acetylcholine Receptor Gene Expression in Mammalian Muscle”The Journal of Biological Chemistry277(18):15638-15646 (2002).
Maddatu et al. “Transgenic Rescue of Neurogenic Atrophy in thenmdMouse Reveals a Role forIghmbp2in dilated Cardiomyopathy”Human Molecular Genetics13(11):1105-1115 (2004).
McKinsey et al. “Identification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases”Molecular and Cellular Biology21(18):6312-6321 (2001).
McKinsey et al. “Signal-Dependent Nuclear Export of a Histone Deacetylase Regulates Muscle Differentiation”Nature408:106-111 (2000).
Mejat et al. “Histone Deacetylase 9 Couples Neuronal Activity to Muscle Chromatin Acetylation and Gene Expression”Nature Neuroscience8(3):313-321 (2005).
Mejat et al. “Synapse-Specific Gene Expression at the Neuromuscular Junction”Ann NY Acad Sci998:53-65 (2003).
Merlie et al. “Myogenin and Acetylcholine Receptor α Gene Promoters Mediate Transcriptional Regulation in Response to Motor Innervation”The Journal of Biological Chemistry269(4):2461-2467 (1994).
Neville et al. “Kinetics of Expression of Ach Receptor Alpha-Subunit mRNA in Denervated and Stimulated Muscle”Neuroreport2(11):655-657 (1991) (Abstract Only).
Sanes and Lichtman. “Development of the Vertebrate Neuromuscular Junction”Annu Rev Neurosci22:389-442 (1999).
Sanes and Lichtman. “Induction, Assembly, Maturation and Maintenance of a Postsynaptic Apparatus”Neuroscience2:791-805 (2001).
Schaeffer et al. “Targeting Transcription to the Neuromuscular Synapse”Neuron31:15-22 (2001).
Siu et al. “Hindlimb Unloading Increases Muscle Content of Cytosolic but Not Nuclear Id2 and p53 Proteins in Young Adult and Aged Rats”J Appl Physiol100:907-916 (2006).
Su et al. “The Depolarization Response Element in Acetylcholine Receptor Genes is a Dual-Function E Box”FEBS Letters366:131-136 (1995).
Tang and Goldman. “Activity-Dependent Gene Regulation in Skeletal Muscle is Mediated by a Histone Deacetylase (HDAC)-Dach2-Myogenin Signal Transduction Cascade”Proc Natl Acad Sci USA103(45):16977-16982 (2006).
Tang et al. “CaM Kinase II-Dependent Phosphorylation of Myogenin Contributes to Activity-Dependent Suppression of nAChR Gene Expression in Developing Rate Myotubes”Cellular Signalling16:551-563 (2004).
Tang et al. “Separate Pathways for Synapse-Specific and Electrical Activity-Dependent Gene Expression in Skeletal Muscle”Development120:1799-1804 (1994).
Walke et al. “Identification and Characterization of a 47 Base Pair Activity-Dependent Enhancer of the Rat Nicotinic Acetylcholine Receptor δ-Subunit Promoter”The Journal of Neuroscience16(11):3641-3651 (1996).
Wu et al. “Regulation of Mitochondrial Biogenesis in Skeletal Muscle by CaMK”Science296:349-352 (2002).
Zhao et al. “The Modular Nature of Histone Deacetylase HDAC4 Confers Phosphorylation-Dependent Intracellul
Cohen Todd
De Renshaw Tomasa Barrientos
Yao Tso-Pang
Duke University
Henley, III Raymond J
Myers Bigel Sibley & Sajovec P.A.
LandOfFree
Methods and compositions for regulating HDAC4 activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for regulating HDAC4 activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for regulating HDAC4 activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4248530